Appian brings low-code speed and automation power to help
drive innovation in drug discovery and scientific
research
MCLEAN, Va., Dec. 15, 2020 /PRNewswire/ -- Appian
(NASDAQ: APPN) today announced that it has joined Accenture's
INTIENT partner ecosystem as a core partner. The ecosystem is
designed to help independent software vendors (ISVs) and life
science companies integrate more effectively to accelerate drug
discovery efforts and improve patient outcomes.
The INTIENT Network is an integral part of Accenture's INTIENT
Platform that enables insights and collaboration across the life
sciences enterprise to improve productivity, efficiency, and
innovation in drug discovery. Accenture has partnered with Appian
to integrate low-code development into the INTIENT platform.
The Appian Low-Code Automation Platform allows enterprises to
build applications up to 20x faster than traditional code. By
providing a single interface that unifies data, process, people and
the digital workforce, Appian helps organizations improve digital
innovation and optimize business outcomes. Industry leaders trust
Appian to improve customer experience, achieve operational
excellence, and simplify global risk management and compliance.
"We are proud to work with Accenture to jointly support
research, innovation, and better outcomes for the Life Sciences
industry," said Marc Wilson, Founder
and Senior Vice President of Global Partnerships and Industries at
Appian. "Our ability to accelerate business processes, unify
enterprise data, and simplify global compliance is why nine of the
world's top 10 drug and biotech organizations use Appian."
As part of the INTIENT partner ecosystem, Appian's platform will
be used across the INTIENT Clinical, INTIENT Patient, INTIENT
Research, and INTIENT Pharmacovigilance product suites.
"Our open partner network is one of the ways we're bringing
innovation to our clients through the Accenture INTIENT platform,"
said Joe Donahue, a Managing
Director in Accenture's Life Sciences practice. "Appian's
integration into this ecosystem as a core partner will allow for
faster development of new and powerful digital capabilities to
drive better results for our Life Sciences customers."
To learn more about Accenture's INTIENT Platform, go to
https://www.accenture.com/us-en/services/life-sciences/intient
To request a free trial of the Appian Low-code Automation
Platform, go to https://www.appian.com/platform/free-trial/.
About Appian
Appian provides a low-code automation platform that accelerates
the creation of high-impact business applications. Many of the
world's largest organizations use Appian applications to improve
customer experience, achieve operational excellence, and simplify
global risk management and compliance. For more information,
visit www.appian.com.